ICON 9
Trial Description:
An international phase III randomised study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy
Lead Cooperative Group:
Trial Number:
Disease Site:
Recurrent Maintenance Ovarian
Trial Status:
Recruiting
Contact person:
lfarrelly